Nunzia Pharmaceutical Company
NUNZ
$0.00
$0.000.00%
OTC PK
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 594.12% | 2.00% | 4,900.00% | -80.00% | -66.67% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | 60.00% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 18.39% | 498.00% | 4,900.00% | -97.78% | 12.50% |
|
|
|||||
| Total Current Assets | 18.39% | 498.00% | 4,900.00% | -97.78% | 12.50% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 18.39% | 498.00% | -1.96% | -46.32% | 5.56% |
|
|
|||||
| Total Accounts Payable | 485.14% | 51.02% | 157.89% | -83.04% | -56.92% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 30.93% | 5.74% | 35.93% | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 135.69% |
| Total Other Current Liabilities | -- | -- | -- | -- | 135.69% |
| Total Current Liabilities | 53.90% | 7.28% | 38.27% | 1.64% | 55.82% |
|
|
|||||
| Total Current Liabilities | 53.90% | 7.28% | 38.27% | 1.64% | 55.82% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 30.93% | 5.74% | 35.93% | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 53.90% | 7.28% | 38.27% | -17.73% | 92.50% |
|
|
|||||
| Common Stock & APIC | 0.08% | 0.02% | 10.42% | 77.05% | 35,771.17% |
| Retained Earnings | -0.12% | -0.01% | -10.44% | -76.92% | -981.95% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | -99.65% |
| Total Common Equity | -62.95% | 11.26% | -40.45% | 15.29% | -107.08% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -62.95% | 11.26% | -40.45% | 15.29% | -107.08% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -62.95% | 11.26% | -40.45% | 15.29% | -107.08% |
|
|
|||||